Irene C. Huffnagel
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Lipidomic biomarkers in plasma correlate with disease severity in adrenoleukodystrophy.
Journal: Communications medicine
Published: November 10, 2023
International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy: A Consensus-Based Approach.
Journal: Neurology
Published: February 03, 2022
Molecular Biomarkers for Adrenoleukodystrophy: An Unmet Need.
Journal: Cells
Published: November 16, 2021
Magnetic resonance spectroscopy as marker for neurodegeneration in X-linked adrenoleukodystrophy.
Journal: NeuroImage. Clinical
Published: March 12, 2021
Optical coherence tomography to measure the progression of myelopathy in adrenoleukodystrophy.
Journal: Annals of clinical and translational neurology
Published: December 29, 2020
Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy.
Journal: Annals of clinical and translational neurology
Published: July 16, 2020
Five men with arresting and relapsing cerebral adrenoleukodystrophy.
Journal: Journal of neurology
Published: June 04, 2020
Postural Body Sway as Surrogate Outcome for Myelopathy in Adrenoleukodystrophy.
Journal: Frontiers in physiology
Published: March 10, 2020
Spinal cord atrophy as a measure of severity of myelopathy in adrenoleukodystrophy.
Journal: Journal of inherited metabolic disease
Published: January 03, 2020
Optical coherence tomography shows neuroretinal thinning in myelopathy of adrenoleukodystrophy.
Journal: Journal of neurology
Published: September 27, 2019
Last Updated: 09/26/2026